ASX - By Stock
|
CU6 |
Re:
Ann: First patient dosed in Phase III prostate cancer trial
|
|
Vivo
|
19 |
6.0K |
5 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
19
|
6.0K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
Vivo
|
362 |
128K |
13 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
362
|
128K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Recruitment closes for a diagnostic Phase II trial in NETs
|
|
Vivo
|
33 |
7.8K |
7 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
33
|
7.8K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
Vivo
|
362 |
128K |
5 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
362
|
128K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
Vivo
|
362 |
128K |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
362
|
128K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
Vivo
|
362 |
128K |
14 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
362
|
128K
|
14
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
2 |
07/10/23 |
07/10/23 |
Charts
|
33K
|
16M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
Vivo
|
1.6K |
965K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
1.6K
|
965K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Vivo
|
24K |
12M |
9 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
24K
|
12M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
This is getting serious
|
|
Vivo
|
230 |
86K |
8 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
230
|
86K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
1 |
22/08/23 |
22/08/23 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
6 |
22/08/23 |
22/08/23 |
Charts
|
33K
|
16M
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Bolsters Antibody Pre-Targeting with IP from MSK
|
|
Vivo
|
40 |
10K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
40
|
10K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Establishes US Center of Excellence for Research
|
|
Vivo
|
26 |
6.8K |
4 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
26
|
6.8K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Chart
|
|
Vivo
|
32 |
18K |
18 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
32
|
18K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
1 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody
|
|
Vivo
|
21 |
9.1K |
3 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
21
|
9.1K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
743 |
339K |
3 |
12/06/23 |
12/06/23 |
ASX - By Stock
|
743
|
339K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
8 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
1 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
7 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
5 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
2 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive final data in 2nd line head and neck cancer at ASCO
|
|
Vivo
|
26 |
11K |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
26
|
11K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
743 |
339K |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
743
|
339K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
743 |
339K |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
743
|
339K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
743 |
339K |
0 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
743
|
339K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Insignia takes 5% stake in IMM
|
|
Vivo
|
18 |
11K |
3 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
18
|
11K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
Vivo
|
11 |
6.5K |
4 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
11
|
6.5K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Vivo
|
57 |
25K |
0 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
57
|
25K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
0 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
37
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
7 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
37
|
12K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
5 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
37
|
12K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Vivo
|
57 |
25K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Vivo
|
57 |
25K |
5 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
37
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
1 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
37
|
12K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Vivo
|
37 |
12K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
37
|
12K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
743 |
339K |
0 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
743
|
339K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Publication of Abstracts for ASCO 2023 Annual Meeting
|
|
Vivo
|
29 |
14K |
23 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
29
|
14K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Publication of Abstracts for ASCO 2023 Annual Meeting
|
|
Vivo
|
29 |
14K |
4 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
29
|
14K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Publication of Abstracts for ASCO 2023 Annual Meeting
|
|
Vivo
|
29 |
14K |
6 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
29
|
14K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Promising New Data in 1st line NSCLC from INSIGHT-003 Trial
|
|
Vivo
|
9 |
5.2K |
34 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
9
|
5.2K
|
34
|
|
ASX - By Stock
|
IMM |
Re:
Chart
|
|
Vivo
|
32 |
18K |
2 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
32
|
18K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
Vivo
|
27 |
15K |
10 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
27
|
15K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
8 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
Vivo
|
27 |
15K |
3 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
27
|
15K
|
3
|
|